Ledger.Open graph →
SEC Form D · filed January 14, 2015

CardioVascular BioTherapeutics, Inc

Offering
$49.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LAS VEGAS, NV
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jon A. Ross · Dallas, TXDirectorGrant A. Gordon · Orange, CADirectorJames R. Richards · Plano, TXDirectorMickael A. Flaa · Las Vegas, NVExecJon S. Ross · Dallas, TXDirectorCalvin A. Wallen · Dallas, TXExecRobert W. Blackburn · Laguna Hills, CADirectorRobert A. Schleizer · Dallas, TXDirectorAl R. Moran · Arlington, TXDirectorSiddharth D. Mehta · Trianon, O4DirectorCalvin A. Wallen · Dallas, TXExecGrant A. Gordon · Orange, CADirectorJames R. Richards · Plano, TXDirectorRobert W. Blackburn · Laguna Hills, CADirectorMickael A. Flaa · Las Vegas, NVExecRobert A. Schleizer · Dallas, TXDirectorAl R. Moran · Arlington, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗